Shares of BTG plc (LON:BTG – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 840 ($10.55) and traded as high as GBX 840 ($10.55). BTG shares last traded at GBX 840 ($10.55), with a volume of 271,742 shares changing hands.
BTG Stock Performance
The stock has a 50 day moving average of GBX 840 and a two-hundred day moving average of GBX 840. The firm has a market capitalization of £3.26 billion and a P/E ratio of 29.47.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Read More
- Five stocks we like better than BTG
- Why Are Stock Sectors Important to Successful Investing?
- MarketBeat Week in Review – 4/29 – 5/3
- How to Effectively Use the MarketBeat Ratings Screener
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- High Flyers: 3 Natural Gas Stocks for March 2022
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.